期刊文献+

腺苷A2受体激动剂对大鼠胰腺缺血再灌注损伤时氧自由基和细胞凋亡的影响 被引量:4

Effect of adenosine A2 receptor agonist on oxygen free radicals and apoptosis during ischemia reperfusion injury in rat pancreas
下载PDF
导出
摘要 目的:研究腺苷A2受体激动剂对大鼠胰腺缺血再灌注损伤时的氧自由基和细胞凋亡的影响.方法:大鼠随机分成3组(n=18),即假手术组、对照组和实验组,对照组和实验组大鼠脾下动脉钳夹30min,假手术组不进行缺血处理;三组再灌注前经阴茎背静脉分别注射生理盐水(2mL/kg)或A2受体激动剂CGS21680(300μg/kg);再灌注15min、30min和60min分别检测胰腺组织中脂质过氧化物(lipoperoxides,LPO)、细胞凋亡的变化以及观察胰腺组织的形态学变化.结果:再灌注15、30和60min后,对照组胰腺组织中LPO和细胞凋亡明显高于假手术组(LPO:8.25±1.15vs1.63±0.46,10.67±2.04vs1.85±0.62,15.31±3.02vs2.02±0.86,均P<0.05;细胞凋亡:0.55±0.08vs0.18±0.04,1.21±0.15vs0.20±0.06,2.63±0.52vs0.23±0.06,均P<0.05或0.01)和实验组(LPO:8.25±1.15vs6.51±1.38,10.67±2.04vs6.84±1.74,15.31±3.02vs10.22±2.91,均P<0.05;细胞凋亡:0.55±0.08vs0.32±0.16,P<0.05;1.21±0.15vs0.44±0.20,2.63±0.52vs0.50±0.43,均P<0.05或0.01);.对照组中,再灌注30min和60min同15min相比,前两者LPO、细胞凋亡增高明显,且差异有统计学意义(P<0.05orP<0.01).假手术组和实验组胰腺组织损伤不明显,而对照组胰腺组织随再灌注时间的延长损伤加重.结论:腺苷A2受体激动剂可减轻大鼠胰腺缺血再灌注损伤时氧自由基和细胞凋亡的发生,从而减轻胰腺缺血再灌注损伤. AIM: To investigate the role of adenosine A2 receptor agonist in protection from production of oxygeon free radicals and induction of apoptosis during ischemia and reperfusion injury in rat pancreas. METHODS: The rats were divided randomly into sham, control and experimental groups. Af-ter 30 min clamping of subsplenic artery, normal saline (2 mL/kg body weight) or A2 receptor agonist CGS21680 (300 μg/kg body weight) was injected via dorsal penis vein, and at 15 min, 30 min and 60 min reperfusion, the changes of lipo-peroxides (LPO), apoptosis and morphology in pancreas tissues were examined. RESULTS: After 15, 30 and 60 min reperfusion, LPO increased significantly in control group compared with the sham operation group (8.25 ± 1.15 vs 1.63 ± 0.46, 10.67 ± 2.04 vs 1.85 ± 0.62, 15.31 ± 3.02 vs 2.02 ± 0.86, all P 〈 0.05) and ex-perimental group (8.25 ± 1.15 vs 6.51 ± 1.38, 10.67 ± 2.04 vs 6.84 ± 1.74, 15.31 ± 3.02 vs 10.22 ± 2.91μmol/L, all P 〈 0.05). Apoptosis increased significantly in control group compared with the sham operation group (0.55 ± 0.08 vs 0.18 ± 0.04, 1.21 ± 0.15 vs 0.20 ± 0.06, 2.63 ± 0.52 vs 0.23 ±0.06, P 〈 0.05 or 0.01) and experimental group (0.55 ± 0.08 vs 0.32 ± 0.16 P 〈 0.05; 1.21 ± 0.15 vs 0.44 ± 0.20, 2.63 ± 0.52 vs 0.50 ± 0.43, all P 〈 0.05 or 0.01). In the control group, compared with 15 min reperfusion, LPO and apoptosis increased significantly at 30 min or 60 min reperfusion (P 〈 0.05 or 0.01). In sham operation group and experimental group, no remarked damage of pancreas was detected, but in control group, the pancreas damage became more serious with the prolonging of reperfusion. CONCLUSION: Adenosine A2 receptor agonist attenuates postischemic production of oxygen free radicals and induction of apoptosis in pan-creas tissues, thereby minimizes the ischemia reperfusion injury.
出处 《世界华人消化杂志》 CAS 北大核心 2008年第27期3099-3102,共4页 World Chinese Journal of Digestology
关键词 腺苷A2受体激动剂 缺血再灌注损伤 氧自由基 细胞凋亡 Adenosine A2 receptor agonist Ischemia reperfusion injury Oxygen free radicals Apoptosis
  • 相关文献

参考文献2

二级参考文献75

  • 1[40]Larsen JL,Ratanasuwan T,Burkman T,Lynch T,Erickson J,Colling C,Lane J,Mack-Shipman L,Lyden E,Loseke M,Miller S,Leone J.Carotid intima media thickness decreases after pancreas transplantation.Transplantation 2002; 73:936-940
  • 2[41]Morrissey PE,Shaffer D,Monaco AP,Conway P,Madras PN.Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease.Arch Surg 1997; 132:358-361; discussion 361-362
  • 3[42]Gross CR,Limwattananon C,Matthees B,Zehrer JL,Savik K.Impact of transplantation on quality of life in patients with diabetes and renal dysfunction.Transplantation 2000; 70:1736-1746
  • 4[43]Kiebert GM,van Oosterhout EC,van Bronswijk H,Lemkes HH,Gooszen HG.Quality of life after combined kidneypancreas or kidney transplantation in diabetic patients with end-stage renal disease.Clin Transplant 1994; 8:239-245
  • 5[44]Sureshkumar KK,Mubin T,Mikhael N,Kashif MA,Nghiem DD,Marcus RJ.Assessment of quality of life after simultaneous pancreas-kidney transplantation.Am J Kidney Dis 2002; 39:1300-1306
  • 6[45]Najarian JS,Sutherland DE,Matas AJ,Steffes MW,Simmons RL,Goetz FC.Human islet transplantation:a preliminary report.Transplant Proc 1977; 9:233-236
  • 7[46]Warnock GL,Kneteman NM,Ryan EA,Rabinovitch A,Rajotte RV.Long-term follow-up after transplantation of insulinproducing pancreatic islets into patients with type 1 (insulindependent) diabetes mellitus.Diabetologia 1992; 35:89-95
  • 8[47]CITR,Collaborative Islet Transplant Registry 2006 Scientific Summary,web.emmes.com/study/isl/reports/reports.htm,2006
  • 9[48]Stock PG,Bluestone JA.Beta-cell replacement for type I diabetes.Annu Rev Med 2004; 55:133-156
  • 10[49]Paty BW,Senior PA,Lakey JR,Shapiro AM,Ryan EA.Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects.Diabetes Technol Ther 2006; 8:165-173

共引文献4

同被引文献33

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部